Table of Content

1 Ultra Short Acting Anesthetic Market Overview
1.1 Product Overview and Scope of Ultra Short Acting Anesthetic
1.2 Ultra Short Acting Anesthetic Segment by Type
1.2.1 Global Ultra Short Acting Anesthetic Market Value Comparison by Type (2024-2034)
1.2.2 Methitural
1.2.3 Byfavo
1.2.4 Methohexital
1.2.5 Thiamylal
1.2.6 Thiopental
1.2.7 Propofol
1.3 Ultra Short Acting Anesthetic Segment by Application
1.3.1 Global Ultra Short Acting Anesthetic Market Value by Application: (2024-2034)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Others
1.4 Global Ultra Short Acting Anesthetic Market Size Estimates and Forecasts
1.4.1 Global Ultra Short Acting Anesthetic Revenue 2018-2029
1.4.2 Global Ultra Short Acting Anesthetic Sales 2018-2029
1.4.3 Global Ultra Short Acting Anesthetic Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Ultra Short Acting Anesthetic Market Competition by Manufacturers
2.1 Global Ultra Short Acting Anesthetic Sales Market Share by Manufacturers (2018-2024)
2.2 Global Ultra Short Acting Anesthetic Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Ultra Short Acting Anesthetic Average Price by Manufacturers (2018-2024)
2.4 Global Ultra Short Acting Anesthetic Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Ultra Short Acting Anesthetic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ultra Short Acting Anesthetic, Product Type & Application
2.7 Ultra Short Acting Anesthetic Market Competitive Situation and Trends
2.7.1 Ultra Short Acting Anesthetic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ultra Short Acting Anesthetic Players Market Share by Revenue
2.7.3 Global Ultra Short Acting Anesthetic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ultra Short Acting Anesthetic Retrospective Market Scenario by Region
3.1 Global Ultra Short Acting Anesthetic Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Ultra Short Acting Anesthetic Global Ultra Short Acting Anesthetic Sales by Region: 2018-2029
3.2.1 Global Ultra Short Acting Anesthetic Sales by Region: 2018-2024
3.2.2 Global Ultra Short Acting Anesthetic Sales by Region: 2024-2029
3.3 Global Ultra Short Acting Anesthetic Global Ultra Short Acting Anesthetic Revenue by Region: 2018-2029
3.3.1 Global Ultra Short Acting Anesthetic Revenue by Region: 2018-2024
3.3.2 Global Ultra Short Acting Anesthetic Revenue by Region: 2024-2029
3.4 North America Ultra Short Acting Anesthetic Market Facts & Figures by Country
3.4.1 North America Ultra Short Acting Anesthetic Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Ultra Short Acting Anesthetic Sales by Country (2018-2029)
3.4.3 North America Ultra Short Acting Anesthetic Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ultra Short Acting Anesthetic Market Facts & Figures by Country
3.5.1 Europe Ultra Short Acting Anesthetic Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Ultra Short Acting Anesthetic Sales by Country (2018-2029)
3.5.3 Europe Ultra Short Acting Anesthetic Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ultra Short Acting Anesthetic Market Facts & Figures by Country
3.6.1 Asia Pacific Ultra Short Acting Anesthetic Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Ultra Short Acting Anesthetic Sales by Country (2018-2029)
3.6.3 Asia Pacific Ultra Short Acting Anesthetic Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ultra Short Acting Anesthetic Market Facts & Figures by Country
3.7.1 Latin America Ultra Short Acting Anesthetic Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Ultra Short Acting Anesthetic Sales by Country (2018-2029)
3.7.3 Latin America Ultra Short Acting Anesthetic Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ultra Short Acting Anesthetic Market Facts & Figures by Country
3.8.1 Middle East and Africa Ultra Short Acting Anesthetic Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Ultra Short Acting Anesthetic Sales by Country (2018-2029)
3.8.3 Middle East and Africa Ultra Short Acting Anesthetic Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ultra Short Acting Anesthetic Sales by Type (2018-2029)
4.1.1 Global Ultra Short Acting Anesthetic Sales by Type (2018-2024)
4.1.2 Global Ultra Short Acting Anesthetic Sales by Type (2024-2029)
4.1.3 Global Ultra Short Acting Anesthetic Sales Market Share by Type (2018-2029)
4.2 Global Ultra Short Acting Anesthetic Revenue by Type (2018-2029)
4.2.1 Global Ultra Short Acting Anesthetic Revenue by Type (2018-2024)
4.2.2 Global Ultra Short Acting Anesthetic Revenue by Type (2024-2029)
4.2.3 Global Ultra Short Acting Anesthetic Revenue Market Share by Type (2018-2029)
4.3 Global Ultra Short Acting Anesthetic Price by Type (2018-2029)
5 Segment by Application
5.1 Global Ultra Short Acting Anesthetic Sales by Application (2018-2029)
5.1.1 Global Ultra Short Acting Anesthetic Sales by Application (2018-2024)
5.1.2 Global Ultra Short Acting Anesthetic Sales by Application (2024-2029)
5.1.3 Global Ultra Short Acting Anesthetic Sales Market Share by Application (2018-2029)
5.2 Global Ultra Short Acting Anesthetic Revenue by Application (2018-2029)
5.2.1 Global Ultra Short Acting Anesthetic Revenue by Application (2018-2024)
5.2.2 Global Ultra Short Acting Anesthetic Revenue by Application (2024-2029)
5.2.3 Global Ultra Short Acting Anesthetic Revenue Market Share by Application (2018-2029)
5.3 Global Ultra Short Acting Anesthetic Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Paion
6.1.1 Paion Corporation Information
6.1.2 Paion Description and Business Overview
6.1.3 Paion Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Paion Ultra Short Acting Anesthetic Product Portfolio
6.1.5 Paion Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AstraZeneca Ultra Short Acting Anesthetic Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Fresenius-Kabi
6.3.1 Fresenius-Kabi Corporation Information
6.3.2 Fresenius-Kabi Description and Business Overview
6.3.3 Fresenius-Kabi Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Fresenius-Kabi Ultra Short Acting Anesthetic Product Portfolio
6.3.5 Fresenius-Kabi Recent Developments/Updates
6.4 BbVie Laboratories
6.4.1 BbVie Laboratories Corporation Information
6.4.2 BbVie Laboratories Description and Business Overview
6.4.3 BbVie Laboratories Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.4.4 BbVie Laboratories Ultra Short Acting Anesthetic Product Portfolio
6.4.5 BbVie Laboratories Recent Developments/Updates
6.5 Baxter Healthcare
6.5.1 Baxter Healthcare Corporation Information
6.5.2 Baxter Healthcare Description and Business Overview
6.5.3 Baxter Healthcare Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Baxter Healthcare Ultra Short Acting Anesthetic Product Portfolio
6.5.5 Baxter Healthcare Recent Developments/Updates
6.6 Braun
6.6.1 Braun Corporation Information
6.6.2 Braun Description and Business Overview
6.6.3 Braun Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Braun Ultra Short Acting Anesthetic Product Portfolio
6.6.5 Braun Recent Developments/Updates
6.7 Maruishi
6.6.1 Maruishi Corporation Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Maruishi Ultra Short Acting Anesthetic Product Portfolio
6.7.5 Maruishi Recent Developments/Updates
6.8 Piramal Healthcare
6.8.1 Piramal Healthcare Corporation Information
6.8.2 Piramal Healthcare Description and Business Overview
6.8.3 Piramal Healthcare Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Piramal Healthcare Ultra Short Acting Anesthetic Product Portfolio
6.8.5 Piramal Healthcare Recent Developments/Updates
6.9 Hikma Pharmaceuticals
6.9.1 Hikma Pharmaceuticals Corporation Information
6.9.2 Hikma Pharmaceuticals Description and Business Overview
6.9.3 Hikma Pharmaceuticals Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Hikma Pharmaceuticals Ultra Short Acting Anesthetic Product Portfolio
6.9.5 Hikma Pharmaceuticals Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Mylan Ultra Short Acting Anesthetic Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Nhwa
6.11.1 Nhwa Corporation Information
6.11.2 Nhwa Ultra Short Acting Anesthetic Description and Business Overview
6.11.3 Nhwa Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Nhwa Ultra Short Acting Anesthetic Product Portfolio
6.11.5 Nhwa Recent Developments/Updates
6.12 Lunan
6.12.1 Lunan Corporation Information
6.12.2 Lunan Ultra Short Acting Anesthetic Description and Business Overview
6.12.3 Lunan Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Lunan Ultra Short Acting Anesthetic Product Portfolio
6.12.5 Lunan Recent Developments/Updates
6.13 Hengrui
6.13.1 Hengrui Corporation Information
6.13.2 Hengrui Ultra Short Acting Anesthetic Description and Business Overview
6.13.3 Hengrui Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Hengrui Ultra Short Acting Anesthetic Product Portfolio
6.13.5 Hengrui Recent Developments/Updates
6.14 Pfizer
6.14.1 Pfizer Corporation Information
6.14.2 Pfizer Ultra Short Acting Anesthetic Description and Business Overview
6.14.3 Pfizer Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Pfizer Ultra Short Acting Anesthetic Product Portfolio
6.14.5 Pfizer Recent Developments/Updates
6.15 Merck
6.15.1 Merck Corporation Information
6.15.2 Merck Ultra Short Acting Anesthetic Description and Business Overview
6.15.3 Merck Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Merck Ultra Short Acting Anesthetic Product Portfolio
6.15.5 Merck Recent Developments/Updates
6.16 Eli Lilly
6.16.1 Eli Lilly Corporation Information
6.16.2 Eli Lilly Ultra Short Acting Anesthetic Description and Business Overview
6.16.3 Eli Lilly Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Eli Lilly Ultra Short Acting Anesthetic Product Portfolio
6.16.5 Eli Lilly Recent Developments/Updates
6.17 Meda pharmaceuticals
6.17.1 Meda pharmaceuticals Corporation Information
6.17.2 Meda pharmaceuticals Ultra Short Acting Anesthetic Description and Business Overview
6.17.3 Meda pharmaceuticals Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Meda pharmaceuticals Ultra Short Acting Anesthetic Product Portfolio
6.17.5 Meda pharmaceuticals Recent Developments/Updates
6.18 Sanofi
6.18.1 Sanofi Corporation Information
6.18.2 Sanofi Ultra Short Acting Anesthetic Description and Business Overview
6.18.3 Sanofi Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Sanofi Ultra Short Acting Anesthetic Product Portfolio
6.18.5 Sanofi Recent Developments/Updates
6.19 Teva Pharmaceutical
6.19.1 Teva Pharmaceutical Corporation Information
6.19.2 Teva Pharmaceutical Ultra Short Acting Anesthetic Description and Business Overview
6.19.3 Teva Pharmaceutical Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Teva Pharmaceutical Ultra Short Acting Anesthetic Product Portfolio
6.19.5 Teva Pharmaceutical Recent Developments/Updates
6.20 Sumitomo Dainippon Pharma
6.20.1 Sumitomo Dainippon Pharma Corporation Information
6.20.2 Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Description and Business Overview
6.20.3 Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Product Portfolio
6.20.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.21 Bausch Health
6.21.1 Bausch Health Corporation Information
6.21.2 Bausch Health Ultra Short Acting Anesthetic Description and Business Overview
6.21.3 Bausch Health Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Bausch Health Ultra Short Acting Anesthetic Product Portfolio
6.21.5 Bausch Health Recent Developments/Updates
6.22 Oak Pharmaceuticals
6.22.1 Oak Pharmaceuticals Corporation Information
6.22.2 Oak Pharmaceuticals Ultra Short Acting Anesthetic Description and Business Overview
6.22.3 Oak Pharmaceuticals Ultra Short Acting Anesthetic Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Oak Pharmaceuticals Ultra Short Acting Anesthetic Product Portfolio
6.22.5 Oak Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ultra Short Acting Anesthetic Industry Chain Analysis
7.2 Ultra Short Acting Anesthetic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ultra Short Acting Anesthetic Production Mode & Process
7.4 Ultra Short Acting Anesthetic Sales and Marketing
7.4.1 Ultra Short Acting Anesthetic Sales Channels
7.4.2 Ultra Short Acting Anesthetic Distributors
7.5 Ultra Short Acting Anesthetic Customers
8 Ultra Short Acting Anesthetic Market Dynamics
8.1 Ultra Short Acting Anesthetic Industry Trends
8.2 Ultra Short Acting Anesthetic Market Drivers
8.3 Ultra Short Acting Anesthetic Market Challenges
8.4 Ultra Short Acting Anesthetic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Ultra Short Acting Anesthetic Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Ultra Short Acting Anesthetic Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Ultra Short Acting Anesthetic Market Competitive Situation by Manufacturers in 2022
Table 4. Global Ultra Short Acting Anesthetic Sales (Tons) of Key Manufacturers (2018-2024)
Table 5. Global Ultra Short Acting Anesthetic Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Ultra Short Acting Anesthetic Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Ultra Short Acting Anesthetic Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Ultra Short Acting Anesthetic Average Price (US$/Ton) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Ultra Short Acting Anesthetic, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Ultra Short Acting Anesthetic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ultra Short Acting Anesthetic, Product Type & Application
Table 12. Global Key Manufacturers of Ultra Short Acting Anesthetic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ultra Short Acting Anesthetic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ultra Short Acting Anesthetic as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ultra Short Acting Anesthetic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Ultra Short Acting Anesthetic Sales by Region (2018-2024) & (Tons)
Table 18. Global Ultra Short Acting Anesthetic Sales Market Share by Region (2018-2024)
Table 19. Global Ultra Short Acting Anesthetic Sales by Region (2024-2029) & (Tons)
Table 20. Global Ultra Short Acting Anesthetic Sales Market Share by Region (2024-2029)
Table 21. Global Ultra Short Acting Anesthetic Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Ultra Short Acting Anesthetic Revenue Market Share by Region (2018-2024)
Table 23. Global Ultra Short Acting Anesthetic Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Ultra Short Acting Anesthetic Revenue Market Share by Region (2024-2029)
Table 25. North America Ultra Short Acting Anesthetic Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Ultra Short Acting Anesthetic Sales by Country (2018-2024) & (Tons)
Table 27. North America Ultra Short Acting Anesthetic Sales by Country (2024-2029) & (Tons)
Table 28. North America Ultra Short Acting Anesthetic Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Ultra Short Acting Anesthetic Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Ultra Short Acting Anesthetic Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Ultra Short Acting Anesthetic Sales by Country (2018-2024) & (Tons)
Table 32. Europe Ultra Short Acting Anesthetic Sales by Country (2024-2029) & (Tons)
Table 33. Europe Ultra Short Acting Anesthetic Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Ultra Short Acting Anesthetic Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Ultra Short Acting Anesthetic Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Ultra Short Acting Anesthetic Sales by Region (2018-2024) & (Tons)
Table 37. Asia Pacific Ultra Short Acting Anesthetic Sales by Region (2024-2029) & (Tons)
Table 38. Asia Pacific Ultra Short Acting Anesthetic Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Ultra Short Acting Anesthetic Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Ultra Short Acting Anesthetic Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Ultra Short Acting Anesthetic Sales by Country (2018-2024) & (Tons)
Table 42. Latin America Ultra Short Acting Anesthetic Sales by Country (2024-2029) & (Tons)
Table 43. Latin America Ultra Short Acting Anesthetic Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Ultra Short Acting Anesthetic Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Ultra Short Acting Anesthetic Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Ultra Short Acting Anesthetic Sales by Country (2018-2024) & (Tons)
Table 47. Middle East & Africa Ultra Short Acting Anesthetic Sales by Country (2024-2029) & (Tons)
Table 48. Middle East & Africa Ultra Short Acting Anesthetic Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Ultra Short Acting Anesthetic Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Ultra Short Acting Anesthetic Sales (Tons) by Type (2018-2024)
Table 51. Global Ultra Short Acting Anesthetic Sales (Tons) by Type (2024-2029)
Table 52. Global Ultra Short Acting Anesthetic Sales Market Share by Type (2018-2024)
Table 53. Global Ultra Short Acting Anesthetic Sales Market Share by Type (2024-2029)
Table 54. Global Ultra Short Acting Anesthetic Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Ultra Short Acting Anesthetic Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Ultra Short Acting Anesthetic Revenue Market Share by Type (2018-2024)
Table 57. Global Ultra Short Acting Anesthetic Revenue Market Share by Type (2024-2029)
Table 58. Global Ultra Short Acting Anesthetic Price (US$/Ton) by Type (2018-2024)
Table 59. Global Ultra Short Acting Anesthetic Price (US$/Ton) by Type (2024-2029)
Table 60. Global Ultra Short Acting Anesthetic Sales (Tons) by Application (2018-2024)
Table 61. Global Ultra Short Acting Anesthetic Sales (Tons) by Application (2024-2029)
Table 62. Global Ultra Short Acting Anesthetic Sales Market Share by Application (2018-2024)
Table 63. Global Ultra Short Acting Anesthetic Sales Market Share by Application (2024-2029)
Table 64. Global Ultra Short Acting Anesthetic Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Ultra Short Acting Anesthetic Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Ultra Short Acting Anesthetic Revenue Market Share by Application (2018-2024)
Table 67. Global Ultra Short Acting Anesthetic Revenue Market Share by Application (2024-2029)
Table 68. Global Ultra Short Acting Anesthetic Price (US$/Ton) by Application (2018-2024)
Table 69. Global Ultra Short Acting Anesthetic Price (US$/Ton) by Application (2024-2029)
Table 70. Paion Corporation Information
Table 71. Paion Description and Business Overview
Table 72. Paion Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 73. Paion Ultra Short Acting Anesthetic Product
Table 74. Paion Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 78. AstraZeneca Ultra Short Acting Anesthetic Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Fresenius-Kabi Corporation Information
Table 81. Fresenius-Kabi Description and Business Overview
Table 82. Fresenius-Kabi Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 83. Fresenius-Kabi Ultra Short Acting Anesthetic Product
Table 84. Fresenius-Kabi Recent Developments/Updates
Table 85. BbVie Laboratories Corporation Information
Table 86. BbVie Laboratories Description and Business Overview
Table 87. BbVie Laboratories Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 88. BbVie Laboratories Ultra Short Acting Anesthetic Product
Table 89. BbVie Laboratories Recent Developments/Updates
Table 90. Baxter Healthcare Corporation Information
Table 91. Baxter Healthcare Description and Business Overview
Table 92. Baxter Healthcare Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 93. Baxter Healthcare Ultra Short Acting Anesthetic Product
Table 94. Baxter Healthcare Recent Developments/Updates
Table 95. Braun Corporation Information
Table 96. Braun Description and Business Overview
Table 97. Braun Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 98. Braun Ultra Short Acting Anesthetic Product
Table 99. Braun Recent Developments/Updates
Table 100. Maruishi Corporation Information
Table 101. Maruishi Description and Business Overview
Table 102. Maruishi Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 103. Maruishi Ultra Short Acting Anesthetic Product
Table 104. Maruishi Recent Developments/Updates
Table 105. Piramal Healthcare Corporation Information
Table 106. Piramal Healthcare Description and Business Overview
Table 107. Piramal Healthcare Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 108. Piramal Healthcare Ultra Short Acting Anesthetic Product
Table 109. Piramal Healthcare Recent Developments/Updates
Table 110. Hikma Pharmaceuticals Corporation Information
Table 111. Hikma Pharmaceuticals Description and Business Overview
Table 112. Hikma Pharmaceuticals Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 113. Hikma Pharmaceuticals Ultra Short Acting Anesthetic Product
Table 114. Hikma Pharmaceuticals Recent Developments/Updates
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 118. Mylan Ultra Short Acting Anesthetic Product
Table 119. Mylan Recent Developments/Updates
Table 120. Nhwa Corporation Information
Table 121. Nhwa Description and Business Overview
Table 122. Nhwa Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 123. Nhwa Ultra Short Acting Anesthetic Product
Table 124. Nhwa Recent Developments/Updates
Table 125. Lunan Corporation Information
Table 126. Lunan Description and Business Overview
Table 127. Lunan Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 128. Lunan Ultra Short Acting Anesthetic Product
Table 129. Lunan Recent Developments/Updates
Table 130. Hengrui Corporation Information
Table 131. Hengrui Description and Business Overview
Table 132. Hengrui Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 133. Hengrui Ultra Short Acting Anesthetic Product
Table 134. Hengrui Recent Developments/Updates
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 138. Pfizer Ultra Short Acting Anesthetic Product
Table 139. Pfizer Recent Developments/Updates
Table 140. Merck Corporation Information
Table 141. Merck Description and Business Overview
Table 142. Merck Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 143. Merck Ultra Short Acting Anesthetic Product
Table 144. Merck Recent Developments/Updates
Table 145. Eli Lilly Corporation Information
Table 146. Eli Lilly Description and Business Overview
Table 147. Eli Lilly Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 148. Eli Lilly Ultra Short Acting Anesthetic Product
Table 149. Eli Lilly Recent Developments/Updates
Table 150. Meda pharmaceuticals Corporation Information
Table 151. Meda pharmaceuticals Description and Business Overview
Table 152. Meda pharmaceuticals Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 153. Meda pharmaceuticals Ultra Short Acting Anesthetic Product
Table 154. Meda pharmaceuticals Recent Developments/Updates
Table 155. Sanofi Corporation Information
Table 156. Sanofi Description and Business Overview
Table 157. Sanofi Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 158. Sanofi Ultra Short Acting Anesthetic Product
Table 159. Sanofi Recent Developments/Updates
Table 160. Teva Pharmaceutical Corporation Information
Table 161. Teva Pharmaceutical Description and Business Overview
Table 162. Teva Pharmaceutical Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 163. Teva Pharmaceutical Ultra Short Acting Anesthetic Product
Table 164. Teva Pharmaceutical Recent Developments/Updates
Table 165. Sumitomo Dainippon Pharma Corporation Information
Table 166. Sumitomo Dainippon Pharma Description and Business Overview
Table 167. Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 168. Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Product
Table 169. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 170. Bausch Health Corporation Information
Table 171. Bausch Health Description and Business Overview
Table 172. Bausch Health Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 173. Bausch Health Ultra Short Acting Anesthetic Product
Table 174. Bausch Health Recent Developments/Updates
Table 175. Oak Pharmaceuticals Corporation Information
Table 176. Oak Pharmaceuticals Description and Business Overview
Table 177. Oak Pharmaceuticals Ultra Short Acting Anesthetic Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 178. Oak Pharmaceuticals Ultra Short Acting Anesthetic Product
Table 179. Oak Pharmaceuticals Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Ultra Short Acting Anesthetic Distributors List
Table 183. Ultra Short Acting Anesthetic Customers List
Table 184. Ultra Short Acting Anesthetic Market Trends
Table 185. Ultra Short Acting Anesthetic Market Drivers
Table 186. Ultra Short Acting Anesthetic Market Challenges
Table 187. Ultra Short Acting Anesthetic Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ultra Short Acting Anesthetic
Figure 2. Global Ultra Short Acting Anesthetic Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Ultra Short Acting Anesthetic Market Share by Type in 2022 & 2029
Figure 4. Methitural Product Picture
Figure 5. Byfavo Product Picture
Figure 6. Methohexital Product Picture
Figure 7. Thiamylal Product Picture
Figure 8. Thiopental Product Picture
Figure 9. Propofol Product Picture
Figure 10. Global Ultra Short Acting Anesthetic Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Ultra Short Acting Anesthetic Market Share by Application in 2022 & 2029
Figure 12. Hospital Use
Figure 13. Clinic Use
Figure 14. Others
Figure 15. Global Ultra Short Acting Anesthetic Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Ultra Short Acting Anesthetic Market Size (2018-2029) & (US$ Million)
Figure 17. Global Ultra Short Acting Anesthetic Sales (2018-2029) & (Tons)
Figure 18. Global Ultra Short Acting Anesthetic Average Price (US$/Ton) & (2018-2029)
Figure 19. Ultra Short Acting Anesthetic Report Years Considered
Figure 20. Ultra Short Acting Anesthetic Sales Share by Manufacturers in 2022
Figure 21. Global Ultra Short Acting Anesthetic Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Ultra Short Acting Anesthetic Players: Market Share by Revenue in 2022
Figure 23. Ultra Short Acting Anesthetic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Ultra Short Acting Anesthetic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Ultra Short Acting Anesthetic Sales Market Share by Country (2018-2029)
Figure 26. North America Ultra Short Acting Anesthetic Revenue Market Share by Country (2018-2029)
Figure 27. U.S. Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Ultra Short Acting Anesthetic Sales Market Share by Country (2018-2029)
Figure 30. Europe Ultra Short Acting Anesthetic Revenue Market Share by Country (2018-2029)
Figure 31. Germany Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Ultra Short Acting Anesthetic Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Ultra Short Acting Anesthetic Revenue Market Share by Region (2018-2029)
Figure 38. China Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Ultra Short Acting Anesthetic Sales Market Share by Country (2018-2029)
Figure 46. Latin America Ultra Short Acting Anesthetic Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Ultra Short Acting Anesthetic Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Ultra Short Acting Anesthetic Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Ultra Short Acting Anesthetic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Ultra Short Acting Anesthetic by Type (2018-2029)
Figure 56. Global Revenue Market Share of Ultra Short Acting Anesthetic by Type (2018-2029)
Figure 57. Global Ultra Short Acting Anesthetic Price (US$/Ton) by Type (2018-2029)
Figure 58. Global Sales Market Share of Ultra Short Acting Anesthetic by Application (2018-2029)
Figure 59. Global Revenue Market Share of Ultra Short Acting Anesthetic by Application (2018-2029)
Figure 60. Global Ultra Short Acting Anesthetic Price (US$/Ton) by Application (2018-2029)
Figure 61. Ultra Short Acting Anesthetic Value Chain
Figure 62. Ultra Short Acting Anesthetic Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed